Deutsche Bank Raises West Pharmaceutical Services Price Target to $450
Deutsche Bank raised its price target on West Pharmaceutical Services to $450 from $420 and maintained its Buy rating.
Deutsche Bank raised its price target on West Pharmaceutical Services to $450 from $420 and maintained its Buy rating.